15 Nov 2024 FDA authorizes the first AI-driven MRI solution for safer Alzheimer’s treatment Member news
09 Nov 2024 Therapeutic potential of a novel mixture of mRNA in nanoparticles overcomes tumor progression Member news
06 Nov 2024 Galapagos to Present Results of Pioneering Innovation in Cancer Cell Therapy at ASH 2024 Member news
01 Nov 2024 reMYND announces positive Phase 2a clinical trial results for treatment of mild-to-moderate Alzheimer’s disease Member news
29 Oct 2024 Rejuvenate Biomed, the NIHR Leicester BRC, and Wellcome Leap partner for Phase 2 Study in COPD-related sarcopenia Member news
25 Oct 2024 Agomab Announces $89 Million Series D Financing to Support Broad Fibrosis-Focused Pipeline Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
